However, more noticeable weight loss typically occurs after about 4 to 8 weeks of consistent use
Side effects are often easier to manage with a gradual, supportive approach: Eat smaller meals and slow down when eating
Semaglutide is a glucagon-like peptide-1 receptor agonist medication
Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al
For patients also dealing with fatigue or hormonal imbalances, we offer integrated testosterone therapy and hormone replacement therapy programs that complement GLP-1 treatment
We find that a licensed GLP-1 receptor agonist modulates epigenetic biomarkers of aging, positioning semaglutide as a candidate gerotherapeutic and laying the groundwork for prospectively powered, mechanism-focused trials aimed at extending healthspan in populations vulnerable to accelerated aging